Characterization of ovolin, an orally active tryptic peptide released from ovalbumin with anxiolytic‐like activity

J. Neurochem. (2012) 122, 356–362.

[1]  T. Kaneko,et al.  Cellular localization of lipocalin‐type prostaglandin D synthase (β‐trace) in the central nervous system of the adult rat , 2000, The Journal of comparative neurology.

[2]  M. Yoshikawa,et al.  Central prostaglandin D(2) exhibits anxiolytic-like activity via the DP(1) receptor in mice. , 2009, Prostaglandins & other lipid mediators.

[3]  A. Lipkowski,et al.  Rubiscolin, a δ selective opioid peptide derived from plant Rubisco , 2001 .

[4]  T. Kaneko,et al.  Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Masaaki Yoshikawa,et al.  β‐Lactotensin derived from bovine β‐lactoglobulin exhibits anxiolytic‐like activity as an agonist for neurotensin NTS2 receptor via activation of dopamine D1 receptor in mice , 2011, Journal of neurochemistry.

[6]  T. Mizushige,et al.  Complement C5a exhibits anxiolytic-like activity via the prostaglandin D2-DP1 receptor system coupled to adenosine A2A and GABAA receptors. , 2012, Prostaglandins & other lipid mediators.

[7]  M. Yoshikawa,et al.  Rubimetide (Met-Arg-Trp) derived from Rubisco exhibits anxiolytic-like activity via the DP1 receptor in male ddY mice , 2008, Peptides.

[8]  S. Narumiya,et al.  Orally administered rubiscolin-6, a δ opioid peptide derived from Rubisco, stimulates food intake via leptomeningeal lipocallin-type prostaglandin D synthase in mice. , 2012, Molecular nutrition & food research.

[9]  M. Fujimiya,et al.  Central prostaglandin D2 stimulates food intake via the neuropeptide Y system in mice , 2008, FEBS letters.

[10]  O. Hayaishi,et al.  Promotion of sleep mediated by the A2a-adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  O. Hayaishi.  Molecular mechanisms of sleep‐wake regulation: roles of prostaglandins D2 and E2 , 1991, The FASEB Journal.

[12]  A. Lipkowski,et al.  Rubiscolin, a delta selective opioid peptide derived from plant Rubisco. , 2001, FEBS letters.

[13]  Kousaku OHINATA,et al.  Soymorphins, Novel μ Opioid Peptides Derived from Soy β-Conglycinin β-Subunit, Have Anxiolytic Activities , 2007 .

[14]  Masaaki Yoshikawa,et al.  Rubiscolin-6, a δ opioid peptide derived from spinach Rubisco, has anxiolytic effect via activating σ1 and dopamine D1 receptors , 2007, Peptides.

[15]  S. Narumiya,et al.  Central PGE2 exhibits anxiolytic‐like activity via EP1 and EP4 receptors in a manner dependent on serotonin 5‐HT1A, dopamine D1 and GABAA receptors , 2011, FEBS letters.

[16]  Y. Urade,et al.  Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Norimasa Kanegawa,et al.  Dipeptide Tyr‐Leu (YL) exhibits anxiolytic‐like activity after oral administration via activating serotonin 5‐HT1A, dopamine D1 and GABAA receptors in mice , 2010, FEBS letters.

[18]  Yoshihiro Urade,et al.  Prostaglandins and adenosine in the regulation of sleep and wakefulness. , 2007, Current opinion in pharmacology.

[19]  T. Kaneko,et al.  Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K. Nakao,et al.  Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution. , 1982, Life sciences.